Pyroptosis in neurodegenerative diseases: What lies beneath the tip of the iceberg?

Int Rev Immunol. 2023;42(4):258-273. doi: 10.1080/08830185.2022.2052064. Epub 2022 Mar 21.

Abstract

Neurodegenerative diseases gradually receive attention with a rapidly aging global population. The hallmark of them is a progressive neuronal loss in the brain or peripheral nervous system due to complex reasons ranging from protein aggregation, immune dysregulation to abnormal cell death. The death style of nerve cell is no longer restricted to apoptosis, autophagy and necrosis as confirmed before. With the successive discoveries of the gasdermin (GSDM) protein family and key caspase molecules in the past several decades, pyroptosis emerges as a novel kind of programmed cell death. A substantial body of evidence has recognized the close connection between pyroptosis and the occurrence and development of neurodegenerative diseases. In this review, we summarize molecular mechanisms of pyroptosis, evidences for pyroptosis involvement in neurodegenerative diseases and finally we hope to provide a novel angle for clinical decision-making.

Keywords: Neurodegenerative disease; Pyroptosis; regulatory mechanism; signal pathway.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Caspases / metabolism
  • Humans
  • Necrosis
  • Neurodegenerative Diseases*
  • Pyroptosis* / physiology

Substances

  • Caspases